Main content
Sorry, this episode is not currently available

More or Less: Antibiotics and the Problem of the Broken Market

Why big pharma won鈥檛 invest in new antibiotics.

If we don鈥檛 get new antibiotics, as they become more resistant it is likely that people will die. It鈥檚 a huge business but there鈥檚 a problem - pharmaceutical companies are reluctant to invest time and money to develop new antibiotics. But why not?

(Image: Computer artwork of bacteria - credit: Science Photo Library)

6 minutes

Last on

Tue 1 Mar 2016 15:23GMT

Broadcast

  • Tue 1 Mar 2016 15:23GMT